These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37282821)

  • 21. Identification of the EH CRISPR-Cas9 system on a metagenome and its application to genome engineering.
    Esquerra-Ruvira B; Baquedano I; Ruiz R; Fernandez A; Montoliu L; Mojica FJM
    Microb Biotechnol; 2023 Jul; 16(7):1505-1523. PubMed ID: 37097160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA and RNA interference mechanisms by CRISPR-Cas surveillance complexes.
    Plagens A; Richter H; Charpentier E; Randau L
    FEMS Microbiol Rev; 2015 May; 39(3):442-63. PubMed ID: 25934119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Packaging and Uncoating of CRISPR/Cas Ribonucleoproteins for Efficient Gene Editing with Viral and Non-Viral Extracellular Nanoparticles.
    Mazurov D; Ramadan L; Kruglova N
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome and transcriptome engineering by compact and versatile CRISPR-Cas systems.
    Aquino-Jarquin G
    Drug Discov Today; 2023 Nov; 28(11):103793. PubMed ID: 37797813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid.
    Li X; Zhong J; Li H; Qiao Y; Mao X; Fan H; Zhong Y; Imani S; Zheng S; Li J
    Front Mol Biosci; 2023; 10():1260883. PubMed ID: 37808520
    [No Abstract]   [Full Text] [Related]  

  • 27. CRISPR/Cas systems for the detection of nucleic acid and non-nucleic acid targets.
    Su W; Li J; Ji C; Chen C; Wang Y; Dai H; Li F; Liu P
    Nano Res; 2023 Mar; ():1-14. PubMed ID: 37359078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A stable DNA-free screening system for CRISPR/RNPs-mediated gene editing in hot and sweet cultivars of Capsicum annuum.
    Kim H; Choi J; Won KH
    BMC Plant Biol; 2020 Oct; 20(1):449. PubMed ID: 33004008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beyond Native Cas9: Manipulating Genomic Information and Function.
    Mitsunobu H; Teramoto J; Nishida K; Kondo A
    Trends Biotechnol; 2017 Oct; 35(10):983-996. PubMed ID: 28739220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular architectures and mechanisms of Class 2 CRISPR-associated nucleases.
    Garcia-Doval C; Jinek M
    Curr Opin Struct Biol; 2017 Dec; 47():157-166. PubMed ID: 29107822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR/Cas Systems towards Next-Generation Biosensing.
    Li Y; Li S; Wang J; Liu G
    Trends Biotechnol; 2019 Jul; 37(7):730-743. PubMed ID: 30654914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization of specific RNA knockdown in mammalian cells with CRISPR-Cas13.
    Burris BJD; Molina Vargas AM; Park BJ; O'Connell MR
    Methods; 2022 Oct; 206():58-68. PubMed ID: 35987443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gold Nanomaterials-Implemented CRISPR-Cas Systems for Biosensing.
    Fu R; Xianyu Y
    Small; 2023 May; 19(21):e2300057. PubMed ID: 36840654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The new generation tool for CRISPR genome editing: CRISPR/Cpf1].
    Yang F; Li Y
    Sheng Wu Gong Cheng Xue Bao; 2017 Mar; 33(3):361-371. PubMed ID: 28941336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Class 2 CRISPR-Cas RNA-guided endonucleases: Swiss Army knives of genome editing.
    Stella S; Alcón P; Montoya G
    Nat Struct Mol Biol; 2017 Nov; 24(11):882-892. PubMed ID: 29035385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Versatile Type V CRISPR Effectors and Their Application Prospects.
    Tong B; Dong H; Cui Y; Jiang P; Jin Z; Zhang D
    Front Cell Dev Biol; 2020; 8():622103. PubMed ID: 33614630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery, classification and application of the CPISPR-Cas13 system.
    Nie X; Wang D; Pan Y; Hua Y; Lü P; Yang Y
    Technol Health Care; 2024; 32(2):525-544. PubMed ID: 37545273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of CRISPR-Mediated Nucleic Acid Detection Technologies and Their Applications in the Livestock Industry.
    Zhang X
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria.
    Gasiunas G; Barrangou R; Horvath P; Siksnys V
    Proc Natl Acad Sci U S A; 2012 Sep; 109(39):E2579-86. PubMed ID: 22949671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel nucleic acid detection strategies based on CRISPR-Cas systems: From construction to application.
    Zhu CS; Liu CY; Qiu XY; Xie SS; Li WY; Zhu L; Zhu LY
    Biotechnol Bioeng; 2020 Jul; 117(7):2279-2294. PubMed ID: 32175589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.